Detailed β-(1→3)-D-glucan and mannan antigen kinetics in patients with candidemia.
Träger J, Dräger S, Mihai S, Cipa F, Busse Grawitz A, Epting T, Meyer R, Rappold E, Held J.
Träger J, et al.
J Clin Microbiol. 2023 Nov 21;61(11):e0059823. doi: 10.1128/jcm.00598-23. Epub 2023 Oct 12.
J Clin Microbiol. 2023.
PMID: 37823667
Free PMC article.
During follow-up, a therapeutic response was associated with decreasing BDG and Mn levels in 84.3% or 70.5% of episodes, respectively. ...In 72.9% and 46.8% of patients, increasing BDG or Mn levels were associated with a fatal outcome. Prior to discharge, BDG and Mn …
During follow-up, a therapeutic response was associated with decreasing BDG and Mn levels in 84.3% or 70.5% of episodes, respectively …